Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol.
Rui Qian YeuRebecca BrandonYannan JiangDale GriffithsKate SmallmanAllan MoffittGlenn DohertyRyan PaulJennie Harré HindmarshTony R MerrimanKerry Macaskill-SmithBrandon Orr-WalkerRinki MurphyPublished in: BMJ open (2020)
ACTRN12618001907235.